Antazoline hydrochloride
SIGMA/A9899
Synonym: 2-
CAS Number: 2508-72-7
Empirical Formula (Hill Notation): C17H19N3 · HCl
Molecular Weight: 301.81
EC Number: 219-719-8
MDL Number: MFCD00058145
Linear Formula: C17H19N3 · HCl
Product Type: Chemical
form | powder |
InChI | 1S/C17H19N3.ClH/c1-3-7-15 |
InChI key | SWKDMSRRIBZZAY-UHFFFAOYSA |
originator | Novartis |
Quality Level | 200 |
SMILES string | Cl.C1CN=C(CN(Cc2ccccc2)c3 |
Biochem/physiol Actions: | Imidazoline agonist; more potent than efaroxan in inducing insulin release from β cells; H1 histamine receptor antagonist. |
Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
Packaging: | 25 g in poly bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H302 + H312 + H332 - H315 - H319 - H335 |
Precautionary statements | P261 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 |
Hazard Codes | Xn |
Risk Statements | 20/21/22-36/37/38 |
Safety Statements | 26-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 12352200 |